Treatment of adult Class II division 2 patient with metal hypersensitivity.

Treatment of adult Class II division 2 patient with metal hypersensitivity. Angle Orthod. 2014 Apr 15; Authors: Haraguchi S, Yamashiro T Abstract This case report describes the orthodontic treatment of an adult female with an Angle Class II division 2 malocclusion with a severe deep bite and a congenitally missing lower incisor. The use of available orthodontic devices and materials was limited because the patient had metal allergies. Following a careful examination and case analysis, the preadjusted edgewise appliances and the microscrew implants were placed after the upper first premolars were extracted. After active treatment, a good facial profile and occlusion were achieved. These results have been maintained for 2 years following completion of the active treatment. PMID: 24731064 [PubMed - as supplied by publisher]
Source: The Angle Orthodontist - Category: Dentistry Authors: Tags: Angle Orthod Source Type: research

Related Links:

International Forum of Allergy&Rhinology, Volume 10, Issue 2, Page 139-140, February 2020.
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Tags: EDITORIAL Source Type: research
International Forum of Allergy&Rhinology, Volume 10, Issue 2, Page 135-137, February 2020.
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Tags: ISSUE INFORMATION Source Type: research
BackgroundKetotifen is a second ‐generation noncompetitive H1‐antihistamine and mast‐cell stabilizer. It is commonly used to treat or prevent allergic conjunctivitis, asthma, chronic urticaria, anaphylaxis, mast‐cell, and other allergic‐type disorders. However, it has never been studied in aspirin‐exacerbated respirato ry disease (AERD), an aggressive phenotype of chronic rhinosinusitis with nasal polyps, where the mast cell plays a prominent role its pathogenesis.MethodsHuman sinonasal epithelial cells were grown at an air ‐liquid interface (ALI). Ketotifen powder was dissolved in saline to make 4 test solut...
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Tags: ORIGINAL ARTICLE Source Type: research
A new study finds that eating a Mediterranean-style diet alters the gut microbiome and is linked to less frailty and better cognitive function in the elderly.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news
Medicare inpatients whose hospitalists relied more on specialist consultation had longer stays, greater costs, and higher subsequent specialist consultation but not better outcomes, a study found.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hospital Medicine News Source Type: news
The quadrivalent version of Fluad was safe and effective against influenza strains included in the vaccine in multiple clinical studies with adults aged 65 years or older.News Alerts
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases News Alert Source Type: news
Eravacycline (ERV), formerly known as TP ‐434, is a novel tetracycline (TET) antibiotic that exhibits in vitro activity against various gram‐positive, gram‐negative aerobic and anaerobic pathogens, including those exhibiting TET‐specific acquired resistance mechanisms. Similar to other TETs, it inhibits protein synthesis through bi nding to the 30S ribosomal subunit. Eravacycline was approved by the United States Food and Drug Administration (FDA) in August 2018 for the treatment of complicated intraabdominal infections (cIAIs) in adults following the Investigating Gram‐Negative Infections Treated with Eravacycli...
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Tags: Review Of Therapeutics Source Type: research
Child influenza-related deaths at this point in the season are the second highest since such deaths were made a nationally notifiable condition in 2004.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
Meeting materials for the Pulmonary-Allergy Drugs Advisory Committee meetings for 2018, including the meeting announcement, briefing materials, committee roster, webcast information, agenda, committee questions, meeting roster, presentation slides, summary minutes, and transcript.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news
This page contains meeting materials for the Pulmonary-Allergy Drugs Advisory Committee meetings for 2017, including the meeting announcement, briefing materials, committee roster, webcast information, agenda, committee questions, meeting roster, presentation slides, summary minutes, and transcript.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news
More News: Allergy | Allergy & Immunology | Dentistry